Ignite Creation Date:
2024-10-25 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06524375
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-23
Brief Title:
A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Brutons Tyrosine Kinase Inhibitor cBTKi for First-Line Chronic Lymphocytic Leukemia 1L CLL to Achieve Deep Durable Remissions to Allow Off-Treatment Period
Sponsor:
Organization:
None